ClinicalTrials.govpublic full text
FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer
metastatic colon adenocarcinoma, metastatic colorectal adenocarcinoma, metastatic microsatellite stable colorectal carcinoma, metastatic rectal adenocarcinoma, stage iv colon cancer ajcc v8, stage iv colorectal cancer ajcc v8, stage iv rectal cancer ajcc v8, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 892590
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.